JPRN-UMIN000012320
Completed
Phase 2
Detection of amyloid deposition in brain and heart using 11CPiBPET/CT imaging - PiBPET/CT study
ational Center for Global Health and Medicine0 sites105 target enrollmentNovember 25, 2013
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Alzheimers disease and myocardial amyloidosis
- Sponsor
- ational Center for Global Health and Medicine
- Enrollment
- 105
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Those who have not signed the informed consent form. Those who are severe systemic condition with serious underlying disease, and may have a difficulty in completion of PET/CT examination. Those who have been decided not appropriate by the principal investigator.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Measurement of amyloid deposit in the brain of idiopathic normal-pressure hydrocephalusJPRN-UMIN000003764Cyclotron and Radioisotope Center (CYRIC), Tohoku University90
Recruiting
Phase 2
Plasma biomarker reflecting cerebral amyloid deposition: a multicenter study for the clinical applicatioAlzheimer's disease Other Dementia Mild cognitive impairment (MCI) Healthy volunteerJPRN-UMIN000023976ational Center for Geriatrics and Gerontology400
Not yet recruiting
Phase 4
Characterization of cerebral amyloid deposition with 18F-Flutemetamol PET and of glucose metabolism with 18F-FDG PET in individuals enrolled in the ALFA project2024-519961-23-00Barcelonabeta Brain Research Center400
Recruiting
Phase 1
Amyloid Brain PET studyDementiaD003704JPRN-jRCTs032230491Takahashi Miwako20
Recruiting
Not Applicable
Clinical Implementation of Amyloid Neurodegeneration and Tau testing in Primary Care.NL-OMON56307Vrije Universiteit Medisch Centrum400